Basic Information
ID: ALA4672601
Type: Functional
Description: Antitumor activity against patient-derived pancreatic cancer cells xenografted in BALB/c mouse model of patient-derived xenograft assessed as inhibition of tumor growth at 6 mg/kg, iv dosed once every 2 days for 18 days relative to control
Format: BAO_0000218
Organism: Homo sapiens
Cell type: Pancreatic cancer cell
Target: Unchecked(ALA612545)
Document: ALA4665887
Antitumor activity against patient-derived pancreatic cancer cells xenografted in BALB/c mouse model of patient-derived xenograft assessed as inhibition of tumor growth at 6 mg/kg, iv dosed once every 2 days for 18 days relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4672601
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 480.52 | 3.99 | 3.99 |